FDA Approves Nasal Spray Influenza Vaccine for Self or Caregiver Administration – The Journal of Healthcare Contracting

FDA Approves Nasal Spray Influenza Vaccine for Self or Caregiver Administration – The Journal of Healthcare Contracting



September 24, 2024 – The U.S. Meals and Drug Administration has authorized FluMist for self- or caregiver-administration. FluMist is authorized for the prevention of influenza illness attributable to influenza virus subtypes A and B in folks 2 to 49 years of age. FluMist is sprayed into the nostril and has been used safely and successfully for a few years. It was initially authorized by the FDA in 2003 to be used in folks 5 to 49 years of age, and in 2007, the FDA authorized FluMist to be used in kids 2 to five years of age. It’s the first vaccine to forestall influenza, higher often called the flu, that doesn’t require a healthcare supplier to manage it.

FluMist accommodates a weakened type of dwell influenza virus strains and is sprayed into the nostril. A prescription continues to be required to obtain FluMist. There at the moment are two authorized choices for receiving FluMist. The vaccine will be administered by a well being care supplier in a well being care setting (together with a pharmacy) or it may be administered by the vaccine recipient or a caregiver who is eighteen years of age or older.

Extra info

Leave a Reply

Your email address will not be published. Required fields are marked *